Free Trial

NEXGEL Q3 2023 Earnings Report

NEXGEL logo
$2.94 +0.07 (+2.26%)
As of 03:43 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NEXGEL EPS Results

Actual EPS
-$0.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NEXGEL Revenue Results

Actual Revenue
$1.22 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NEXGEL Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Remove Ads

NEXGEL Earnings Headlines

Contrasting TELA Bio (NASDAQ:TELA) & NEXGEL (NASDAQ:NXGL)
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
See More NEXGEL Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NEXGEL? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NEXGEL and other key companies, straight to your email.

About NEXGEL

NEXGEL (NASDAQ:NXGL) manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

View NEXGEL Profile

More Earnings Resources from MarketBeat